Indian Pharmacopoeia Commission

ADRMS User Manual for Stakeholders on Medical Device Adverse Event Reporting

Posted by: Prabhas Chakraborty August 31, 2026

7
Comments Off on ADRMS User Manual for Stakeholders on Medical Device Adverse Event Reporting
31st August, 2026

NCC-MvPI Issues ADRMS User Manual for Medical Device Adverse Event Reporting

Posted by: Hitesh Gupta August 31, 2026

7
Comments Off on NCC-MvPI Issues ADRMS User Manual for Medical Device Adverse Event Reporting
31st August, 2026

Indian Pharmacopoeia 2026- Amendment Lists

Posted by: Hitesh Gupta June 29, 2026

7
Comments Off on Indian Pharmacopoeia 2026- Amendment Lists
29th June, 2026

Strengthening Adverse Event Reporting under the Materiovigilance Programme of India (MvPI) – Compliance by Medical Device Marketing Authorisation Holders

Posted by: Prabhas Chakraborty February 17, 2026

What's New 2?

Regulation/Guidelines

The Cosmeceuticals Grey Zone: When a Cosmetic Claim Risks Becoming a Drug Claim

“Cosmeceutical” is a popular marketing word. It suggests something more powerful than an ordinary Cosmetic — a product that treats skin condition, not just improves appearance. The problem is that...

7th September, 2026

Regulation/Guidelines

Ingredient Safety Dossiers: Building a Defensible Package for Novel Actives

Companies developing Cosmetics with new or unusual active ingredients face a higher regulatory bar in India than those using well-established formulations. Understanding what “new” means under the Cosmetics Rules, 2020,...

2nd September, 2026

Regulation/Guidelines

Cosmetic Claims Substantiation: What Counts as Evidence Under Indian Rules

Walk down any Cosmetics aisle and you will see claims like “clinically proven,” “dermatologist tested,” or “reduces fine lines in two weeks.” These claims sell products — but under the...

26th August, 2026

Regulation/Guidelines

AI/ML-Based Medical Devices — Emerging Regulatory Questions

Traditional Medical Device regulation assumes a fixed product: what’s approved is what ships, indefinitely, until a formal change is filed and reviewed. Adaptive AI and machine learning algorithms break that...